147 related articles for article (PubMed ID: 37290894)
1. Screening of novel serum biomarkers for gastric cancer in coastal populations using a protein microarray.
Yi Y; Nan R; Lu J; Liang D; Zhao S; Wang X; Zhang H; Chen B; Chen J; Zheng Z; You T; Chen T; Chen X; Wang W; Lin L; Chen Y; Liu S; Huang Y; Yu Y; Lu M; Li P; Huang H; Zhou G; Lin X; Wu H; Shen X; Sun W
Cancer Sci; 2023 Aug; 114(8):3396-3410. PubMed ID: 37290894
[TBL] [Abstract][Full Text] [Related]
2. A targeted proteomics approach reveals a serum protein signature as diagnostic biomarker for resectable gastric cancer.
Shen Q; Polom K; Williams C; de Oliveira FMS; Guergova-Kuras M; Lisacek F; Karlsson NG; Roviello F; Kamali-Moghaddam M
EBioMedicine; 2019 Jun; 44():322-333. PubMed ID: 31151932
[TBL] [Abstract][Full Text] [Related]
3. NAD(P)-dependent steroid dehydrogenase-like protein and neutral cholesterol ester hydrolase 1 serve as novel markers for early detection of gastric cancer identified using quantitative proteomics.
Xiao Y; Xie J; Liu L; Huang W; Han Q; Qin J; Liu S; Jiang Z
J Clin Lab Anal; 2021 Feb; 35(2):e23652. PubMed ID: 33219617
[TBL] [Abstract][Full Text] [Related]
4. Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients.
Toiyama Y; Tanaka K; Kitajima T; Shimura T; Imaoka H; Mori K; Okigami M; Yasuda H; Okugawa Y; Saigusa S; Ohi M; Inoue Y; Mohri Y; Goel A; Kusunoki M
Carcinogenesis; 2015 Dec; 36(12):1474-83. PubMed ID: 26420253
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of serum tRF-23-Q99P9P9NDD as a potential biomarker for the clinical diagnosis of gastric cancer.
Zhang Y; Gu X; Qin X; Huang Y; Ju S
Mol Med; 2022 Jun; 28(1):63. PubMed ID: 35690737
[TBL] [Abstract][Full Text] [Related]
6. Identification of Serum Biomarkers for Gastric Cancer Diagnosis Using a Human Proteome Microarray.
Yang L; Wang J; Li J; Zhang H; Guo S; Yan M; Zhu Z; Lan B; Ding Y; Xu M; Li W; Gu X; Qi C; Zhu H; Shao Z; Liu B; Tao SC
Mol Cell Proteomics; 2016 Feb; 15(2):614-23. PubMed ID: 26598640
[TBL] [Abstract][Full Text] [Related]
7. Genome-Wide lncRNA Microarray Profiling Identifies Novel Circulating lncRNAs for Detection of Gastric Cancer.
Zhang K; Shi H; Xi H; Wu X; Cui J; Gao Y; Liang W; Hu C; Liu Y; Li J; Wang N; Wei B; Chen L
Theranostics; 2017; 7(1):213-227. PubMed ID: 28042329
[TBL] [Abstract][Full Text] [Related]
8. Serum microRNA-381: A Potential Marker for Early Diagnosis of Gastric Cancer.
Li Y; Sun H; Guan J; Ji T; Wang X
Yonsei Med J; 2019 Aug; 60(8):720-726. PubMed ID: 31347326
[TBL] [Abstract][Full Text] [Related]
9. Screening of Potential Biomarkers for Gastric Cancer with Diagnostic Value Using Label-free Global Proteome Analysis.
Song Y; Wang J; Sun J; Chen X; Shi J; Wu Z; Yu D; Zhang F; Wang Z
Genomics Proteomics Bioinformatics; 2020 Dec; 18(6):679-695. PubMed ID: 33607292
[TBL] [Abstract][Full Text] [Related]
10. Multiple cytokine profiling in serum for early detection of gastric cancer.
Li J; Xu L; Run ZC; Feng W; Liu W; Zhang PJ; Li Z
World J Gastroenterol; 2018 Jun; 24(21):2269-2278. PubMed ID: 29881236
[TBL] [Abstract][Full Text] [Related]
11. Salivary glycopatterns as potential biomarkers for diagnosis of gastric cancer.
Shu J; Yu H; Li X; Zhang D; Liu X; Du H; Zhang J; Yang Z; Xie H; Li Z
Oncotarget; 2017 May; 8(22):35718-35727. PubMed ID: 28415698
[TBL] [Abstract][Full Text] [Related]
12. S100A9 as a novel diagnostic and prognostic biomarker in human gastric cancer.
Zhao Z; Zhang C; Zhao Q
Scand J Gastroenterol; 2020 Mar; 55(3):338-346. PubMed ID: 32172630
[No Abstract] [Full Text] [Related]
13. Serum Helicobacter pylori KatA and AhpC antibodies as novel biomarkers for gastric cancer.
Zhang B; Li HL; Fan Q; Guo F; Ren XY; Zhou HB; Zhu JW; Zhao YS; Tian WJ
World J Gastroenterol; 2016 Jun; 22(21):5060-7. PubMed ID: 27275098
[TBL] [Abstract][Full Text] [Related]
14. S100A9, GIF and AAT as potential combinatorial biomarkers in gastric cancer diagnosis and prognosis.
Wu W; Juan WC; Liang CR; Yeoh KG; So J; Chung MC
Proteomics Clin Appl; 2012 Apr; 6(3-4):152-62. PubMed ID: 22532451
[TBL] [Abstract][Full Text] [Related]
15. Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients.
Corona G; Cannizzaro R; Miolo G; Caggiari L; De Zorzi M; Repetto O; Steffan A; De Re V
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518896
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of macrophage inhibitory cytokine 1 as a novel prognostic biomarkers for early gastric cancer screening.
Ge X; Zhang X; Ma Y; Chen S; Chen Z; Li M
J Clin Lab Anal; 2021 Jan; 35(1):e23568. PubMed ID: 32918498
[TBL] [Abstract][Full Text] [Related]
17. Exosomal miR-1246 in serum as a potential biomarker for early diagnosis of gastric cancer.
Shi Y; Wang Z; Zhu X; Chen L; Ma Y; Wang J; Yang X; Liu Z
Int J Clin Oncol; 2020 Jan; 25(1):89-99. PubMed ID: 31506750
[TBL] [Abstract][Full Text] [Related]
18. Serum ENA78/CXCL5, SDF-1/CXCL12, and their combinations as potential biomarkers for prediction of the presence and distant metastasis of primary gastric cancer.
Lim JB; Chung HW
Cytokine; 2015 May; 73(1):16-22. PubMed ID: 25689618
[TBL] [Abstract][Full Text] [Related]
19. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
20. A Disintegrin and Metalloproteinase 8 as a Potential Blood Biomarker for Early Diagnosis of Gastric Cancer.
Chung HW; Kim JJ; Choi JI; Lee HR; Lim JB
Yonsei Med J; 2019 Aug; 60(8):713-719. PubMed ID: 31347325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]